Ocera Therapeutics Inc. buy melinda
Start price
06.12.12
/
50%
€6.10
Target price
06.06.13
€7.20
Performance (%)
-26.18%
End price
06.06.13
€4.50
Summary
This prediction ended on 06.06.13 with a price of €4.50. The prediction for Ocera Therapeutics Inc. disappointed with a performance of -26.18%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ocera Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 1.085% | -1.655% | 13.297% | 57.692% |
| iShares Nasdaq 100 | -1.665% | -3.137% | 2.218% | 83.804% |
| iShares Nikkei 225® | 3.863% | 6.947% | 22.818% | 56.282% |
| iShares S&P 500 | 0.111% | -1.320% | 1.445% | 57.791% |
Comments by melinda for this prediction
In the thread Ocera Therapeutics Inc. diskutieren
Medikamente
Tranzyme ist ein Unternehmen für Wirkstoffforschung und-entwicklung Erkrankungen mit Innenohrschwerhörigkeit verbunden
(Laufzeit überschritten)
Stopped prediction by melinda for Ocera Therapeutics Inc.
Ocera Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.14
25.04.17
25.04.17
€1.35
25.10.17
25.10.17
-19.00%
25.10.17
25.10.17
Ocera Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.34
19.03.17
19.03.17
€2.26
13.04.17
13.04.17
-5.60%
13.04.17
13.04.17
Ocera Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.24
09.03.17
09.03.17
€2.26
10.03.17
10.03.17
7.94%
10.03.17
10.03.17
Ocera Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.59
08.02.17
08.02.17
€0.90
08.03.17
08.03.17
67.69%
08.03.17
08.03.17